<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Retrovirology</journal-id><journal-id journal-id-type="iso-abbrev">Retrovirology</journal-id><journal-title-group><journal-title>Retrovirology</journal-title></journal-title-group><issn pub-type="epub">1742-4690</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27160192</article-id><article-id pub-id-type="pmc">4862173</article-id><article-id pub-id-type="publisher-id">264</article-id><article-id pub-id-type="doi">10.1186/s12977-016-0264-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5&#x000a0;log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Loret</surname><given-names>Erwann P.</given-names></name><address><email>erwann.loret@univ-amu.fr</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Darque</surname><given-names>Albert</given-names></name><address><email>albert.darque@ap-hm.fr</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Jouve</surname><given-names>Elisabeth</given-names></name><address><email>elisabeth.jouve@ap-hm.fr</email></address><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Loret</surname><given-names>Elvenn A.</given-names></name><address><email>elvennloret@laposte.net</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Nicolino-Brunet</surname><given-names>Corinne</given-names></name><address><email>corinne.brunet@ap-hm.fr</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Morange</surname><given-names>Sophie</given-names></name><address><email>sophie.sorange@ap-hm.fr</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Castanier</surname><given-names>Elisabeth</given-names></name><address><email>elisabeth.castanier@ap-hm.fr</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Casanova</surname><given-names>Josiane</given-names></name><address><email>josiane.casanova@ap-hm.fr</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Caloustian</surname><given-names>Christine</given-names></name><address><email>christine.caloustian@ap-hm.fr</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Bornet</surname><given-names>Charl&#x000e9;ric</given-names></name><address><email>charleric.bornet@ap-hm.fr</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Coussirou</surname><given-names>Julie</given-names></name><address><email>julie.coussirou@hotmail.fr</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Boussetta</surname><given-names>Jihen</given-names></name><address><email>jihenboussetta@hotmail.com</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Couallier</surname><given-names>Vincent</given-names></name><address><email>vincent.couallier@u-bordeaux.fr</email></address><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Blin</surname><given-names>Olivier</given-names></name><address><email>olivier.blin@ap-hm.fr</email></address><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Dussol</surname><given-names>Bertrand</given-names></name><address><email>bertrand.dussol@ap-hm.fr</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Ravaux</surname><given-names>Isabelle</given-names></name><address><email>isabelle.ravaux@ap-hm.fr</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>ETRAV Laboratory, Faculty of Pharmacy, Centre National de la Recherche Scientifique (CNRS), Aix Marseille University, 27 Boulevard Jean Moulin, 13385 Marseille, France </aff><aff id="Aff2"><label/>Centre d&#x02019;Investigation Clinique, Assistance Publique &#x02013;H&#x000f4;pitaux de Marseille (AP-HM), University Hospital Center (UHC) &#x000ab;la Conception&#x000bb;, 147 Bd Baille, 13385 Marseille, France </aff><aff id="Aff3"><label/>Pharmacie Usage Interne, AP-HM, UHC &#x000ab;la Conception&#x000bb;, 147 Bd Baille, 13385 Marseille, France </aff><aff id="Aff4"><label/>Centre de Pharmacologie Clinique et Evaluations Th&#x000e9;rapeutiques (AP-HM), UHC &#x000ab;la Timone&#x000bb;, 28 Boulevard Jean Moulin, 13385 Marseille, France </aff><aff id="Aff5"><label/>Unit&#x000e9; Mixte de Recherche CNRS 5251, Institut de Math&#x000e9;matique de Bordeaux, CNRS, Bordeaux 2 University, 33000 Bordeaux, France </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>13</volume><elocation-id>35</elocation-id><permissions><copyright-statement>&#x000a9; Loret et al. 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><related-article related-article-type="corrected-article" id="d30e75" ext-link-type="doi" xlink:href="10.1186/s12977-016-0251-3"/><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Erratum to: Retrovirology (2016) 13:21 DOI 10.1186/s12977-016-0251-3</title><p>The original version of this article unfortunately contained a mistake. The &#x0201c;Acknowledgement&#x0201d; section was incorrect and included Dr. Catherine Tamalet. Dr. Catherine Tamalet should not be included in the &#x0201c;Acknowledgement&#x0201d; section for the following reasons:</p><p>Dr. Catherine Tamalet requests to be withdrawn from the &#x0201c;Acknowledgements&#x0201d; section in this article, on the following grounds: (a) No permission was asked of her to be acknowledged. (b) She did not read the manuscript before its publication. (c) The method depicted in the &#x0201c;Methods&#x0201d; section to quantify HIV DNA [&#x0201c;Generic HIV assay (Biocentric, Bandol, Provence) with a cut off of 20 copies/million of peripheral blood mononuclear cells (PBMC)&#x0201d;] is not the method employed in her laboratory. Dr. Tamaret routinely employs an &#x0201c;in-House&#x0201d; method with a cut-off of 20 copies. Dr. Thamalet was in the acknowledgement for fruitful discussion and not for her participation to the study.</p><p>Dr. Catherine Tamalet has been removed from the original article [<xref ref-type="bibr" rid="CR1">1</xref>].</p></sec></body><back><fn-group><fn><p>The online version of the original article can be found under doi:10.1186/s12977-016-0251-3.</p></fn></fn-group><ref-list id="Bib1"><title>Reference</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loret</surname><given-names>EP</given-names></name><etal/></person-group><article-title>Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5&#x000a0;log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial</article-title><source>Retrovirology</source><year>2016</year><volume>13</volume><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/s12977-016-0251-3</pub-id><pub-id pub-id-type="pmid">27036656</pub-id></element-citation></ref></ref-list></back></article>